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Purpose. Striatal single photon emission computed tomography (SPECT) imaging of the dopaminergic system is becoming
increasingly used for clinical and research studies. The question about the value of nonuniform attenuation correction has
become more relevant with the increasing availability of hybrid SPECT-CT scanners. In this study, the value of nonuniform
attenuation correction and correction for collimator blurring were determined using both phantom data and patient data.
Methods. SPECT imaging was performed using 7 anthropomorphic phantom measurements, and 14 patient studies using [I-
123]-FP-CIT (DATSCAN). SPECT reconstruction was performed using uniform and nonuniform attenuation correction and
collimator blurring corrections. Recovery values (phantom data) or average-speciﬁc uptake ratios (patient data) for the diﬀerent
reconstructions were compared at similar noise levels. Results. For the phantom data, improved recovery was found with
nonuniform attenuation correction and collimator blurring corrections, with further improvement when performed together.
However, for patient data the highest average speciﬁc uptake ratio was obtained using collimator blurring correction without
nonuniform attenuation correction, probably due to subtle SPECT-CT misregistration. Conclusions. This study suggests that an
optimal brain SPECT reconstruction (in terms of the lowest bias) in patients would include a correction for collimator blurring
and uniform attenuation correction.
1.Introduction
Striatal single photon emission computed tomography
(SPECT) imaging of the dopaminergic system is becoming
increasingly used for clinical and research studies. Depend-
ing on the radiopharmaceutical, striatal uptake of activity
may be a measure of binding to presynaptic receptors,
for example, dopamine transporters (DAT), or postsynaptic
receptors belonging to various neurotransmitter systems
and/or subtypes thereof. The accurate quantiﬁcation of
striatal uptake with these studies is frequently important
for their utilization in the clinical and research context.
Accurate quantiﬁcation of striatal SPECT imaging needs
to take into account a number of factors that degrade
image quality. These include photon attenuation, collimator
blurring, photon scatter, and the limited spatial resolution
of SPECT systems resulting in decreased count densities via
partial volume eﬀects [1].
Attenuation correction (AC) is implemented to correct
for lower counts obtained from deeper brain structures. An
early study using phantom data showed the value of iterative
reconstructionincorporatingcorrectionsforattenuationand
collimator blurring [2]. A simulation study showed that
without any correction striatal recovery is underestimated
by about 90%, improving to about 50% with attenuation
correction (AC) and correction for scatter [3].
Uniform attenuation correction has a well-established
role in brain SPECT studies [3–9]. Nonuniform attenuation2 International Journal of Molecular Imaging
correctionhasbeenfoundtoresultinamodestimprovement
in the quantiﬁcation of regional cerebral blood ﬂow (rCBF)
studies [10–12]. The possible use of nonuniform attenu-
ation correction has also become more relevant in recent
years in light of the increasing availability of hybrid SPECT-
computed tomography (CT) scanners.
Arguably the most robust and commonly used uniform
attenuation correction technique is that described by Chang
[13]. This technique is based on two assumptions: (1) the
scalp contour can be easily deﬁned, (2) attenuation is con-
stant throughout the head. It can be argued that while
both of these assumptions have limitations in the context of
brain SPECT imaging, radiopharmaceuticals concentrating
predominantlyinthebasalganglia(asopposedtothecortex)
may result in SPECT images that are less reliable for the
accurate deﬁnition of the scalp contour.
In a study by Koch et al. [14] using uniform attenuation
correction, the mean percentage diﬀerence between the
measured and the predicted speciﬁc ratio (i.e., the ratio of
activity in a striatal volume of interest (VOI) and an occipital
background VOI) varied from 6.5 to 9.3% for diﬀerent
gamma camera/collimator combinations. It is possible that
a signiﬁcant proportion of this variability may have been
due to diﬃculty in accurately deﬁning the outline of the
scalp from these images. While it is accepted that attenuation
correction is required for striatal SPECT imaging, the value
ofnonuniformasopposedtouniformattenuationcorrection
remains an issue requiring further clariﬁcation.
The ﬁnite length and width of collimator holes results
in blurring of SPECT images. Software is commercially
available for the reconstruction of SPECT images which
correct for collimator blurring. Algorithms can allow for a
ﬁxed point spread function (PSF), or for the incorporation
of a PSF which varies with distance from the collimator.
Previous modeling studies [6, 7, 15] have demonstrated an
improvement in signal recovery of 8–23% using these cor-
rections. Some patient data has also been published showing
the superiority of iterative reconstruction incorporating cor-
rection for collimator blurring over ﬁltered backprojection
[16, 17].
Another important source of image degradation is pho-
ton scatter, which can be corrected for by using a number
of approaches [1, 15, 18, 19]. Scatter correction is included
in simulations of striatal imaging in combination with other
techniques [3, 15], independently contributing to a 12%
improvement in recovery when using a parallel hole colli-
mator [15]. Correction for partial volume eﬀects have been
found to be particularly important in improving recovery
values in simulation studies [3, 15]. This has also been
observed in a patient study [20]. An important challenge
in techniques for correction of partial volume eﬀects, how-
ever, is the requirement for a coregistered high-resolution
anatomical image such as a Magnetic Resonance Imaging
study. Corrections for photon scatter and partial volume
eﬀects will not however be studied in this paper.
In this study, the value for striatal SPECT imaging of
(1) nonuniform attenuation correction using a low-dose CT
(on a hybrid SPECT-CT scanner), and (2) constant and
depth dependent corrections for collimator blurring, will be
determinedusingdataacquiredbothusingananthropomor-
phic striatal phantom, and from patient studies.
2. Methods
2.1. Phantom Measurements. All phantom measurements
were performed using an anthropomorphic basal ganglia
phantom commercially available from Radiology Support
Devices Inc. (Long Beach, CA, USA). The study was per-
formed using 7 phantom SPECT-CT studies, using 14 dif-
ferent speciﬁc uptake ratios (SUR) of Iodine-123, based on
the following formula:
SUR =
striatal activity −background activity
background activity
. (1)
The study was performed using a methodology previously
described [14]. All solutions were prepared in identical vials
before the initial phantom SPECT acquisition. To minimise
adhesion of I-123 to the plastic chamber walls, a 0.1M
sodiumiodidesolutionwasusedasthebasisforthemixtures.
The striatal chambers (caudate and putamen chamber) on
each side were ﬁlled with an identical activity concentration,
with diﬀerent activity concentrations on the left and right
sides for each acquisition. For each successive acquisition,
thestriatalchamberswereemptied, ﬂushed,andthenreﬁlled
with the next pair of concentrations. The large chamber
simulating nonspeciﬁc background activity in the remainder
of the brain was reﬁlled for each acquisition with a similar
activity of 5kBq/mL, thus remaining similar during the
whole experiment. SUR values were varied over a range
approximating that seen in clinical practice.
To accurately determine the true SUR values achieved in
the phantom, two separate 400μL samples were taken from
eachofthechambersdirectlyaftertheSPECTmeasurements,
andtheactivityconcentrationsofthesamplesweremeasured
in a well counter (energy window 140–220keV, counting
time 10 minutes). The average counts/volume of each of the
two identical samples was used to determine the true SUR
values, using formula (1).
2.2. SPECT-CT Imaging. Data were acquired using a GE
Hawkeye SPECT-CT gamma camera (GE Medical Systems,
USA), equipped with low-energy high-resolution parallel
hole collimators. The gamma camera operation and quality
control conformed to that recommended by the camera
manufacturers.
SPECT projection data were acquired with a 128 × 128
matrix with a zoom factor of 1.5, giving a pixel size of
2.95mm. A circular orbit with a rotational radius of 15cm
( t oc o l l i m a t o rs u r f a c e )w a sc h o s e nf o ra l lp h a n t o ma c q u i -
sitions. Acquisition was performed in step and shoot mode
with both heads going through 120 steps each separated
by 3 degrees. Each projection was acquired for 25 seconds,
giving a total SPECT imaging time of about 50 minutes.
Data were acquired at 159keV with a 15% window. The
SPECT acquisition was immediately followed by a low-dose
CT study. This acquisition was done in accordance with the
new guidelines of the EANM [21].International Journal of Molecular Imaging 3
2.3. Reconstruction. All SPECT data were reconstructed with
an ordered subsets expectation maximization (OSEM) algo-
rithm [22] using a Hermes workstation (Nuclear Diagnos-
tics, UK). Attenuation correction and collimator blurring
correction was performed during the iterative reconstruc-
tion. No ﬁltering was applied after reconstruction. For each
phantom measurement, one of 2 attenuation correction
options and 3 collimator blurring correction options were
performed resulting in 6 diﬀerent combinations of recon-
structions per acquisition. The 2 attenuation correction
options were (1) uniform AC using Chang’s method (μ =
0.11/cm), and (2) nonuniform AC using the low-dose CT
study. The 3 collimator blurring correction options were (1)
no correction, (2) correction using a constant point spread
function, (3) correction using a point spread function which
varied as a function of distance from the collimator.
All reconstructions were performed using 30 subsets and
10 iterations. This was chosen to ensure convergence [23]
of the mean activity in a region and was based on the
analysis of a single patient study using 123I-ﬂuoropropyl-
carbomethoxy-3β-(4-iodophenyltropane) (FP-CIT). On the
measured attenuation maps, the phantom chambers were
noted to have an attenuation coeﬃcient of about 0.15/cm.
This value is consistent with what would be expected for a
0.1M sodium iodide solution [24] .I no r d e rt od e t e rm i n et h e
eﬀect of the μ value used during the attenuation correction
on SUR, we reconstructed a single phantom study with μ
values varying from 0 to 0.5/cm. Speciﬁcally for μ values
of 0.10/cm to 0.15/cm, the SUR values varied from 2.68
to 2.76 leading to a maximum variation of 3%. Uniform
attenuation correction was therefore performed according
to EANM guidelines using μ = 0.11/cm [21, 25]. Placement
of the scalp ellipse was complicated in the phantom studies
by the absence of scalp activity. Using an attenuation map
it was established that the average scalp thickness on the
phantom was 11.8mm (4 pixels). The position of the scalp
was therefore approximated by placing an ellipse over the
edge of the brain and expanding it radially by 11.8mm (4
pixels).
Depth-dependent collimator blurring was performed
using a linear relationship between distance and the full
width at half maximum (FWHM) of the point spread
function. We used two diﬀerent methods in this study:
method 1 was based on a measurement (intercept =
3.5mmFWHM, slope = 0.033mm/mm) while method 2
(intercept = 5.3mmFWHM, slope = 0.075mm/mm) was
obtained by determining the values which corresponded
to an optimal ratio of measured SUR to true SUR for a
single independent phantom study. Nondepth-dependent
correction for collimator blurring was performed using
a constant point spread function of 9.4mmFWHM or
16.3mmFWHM. The ﬁrst value corresponds to the default
value in the Hermes software in our institution, while the
latter was again obtained by the optimization procedure
described above for the depth dependent method.
Each of the reconstructed images was smoothed using a
Gaussian kernel varying from 1 to 16mmFWHM in 1mm
increments.
2.4. Analysis. A phantom CT study was performed with the
main brain volume ﬁlled with water, while the striatal vol-
umescontainedair,whichwillbereferredtoasthephantom-
air study. The CT image derived from the phantom-air
study, and all reconstructed SPECT images and CT-based
attenuation maps from the 8 phantom SPECT-CT studies
were converted from interﬁle to ANALYZE format using
MRIcro software [26]. The reconstructed SPECT images
and CT based attenuation maps were all coregistered to
the same space as the phantom-air study using a mutual
information algorithm with Statistical Parametric Mapping
software (SPM version 2, http://www.ﬁl.ion.ucl.ac.uk/spm/,
Wellcome Department of Cognitive Neurology, UK). Using
MRIcroandthephantom-airCTimage,3-dimensionalVOIs
were drawn for the left striatum, right striatum, and a
background volume located posteriorly in the main brain
volume (Figure 1(a)). In each voxel of the two striatal
VOIs, the speciﬁc uptake ratio (SUR) was calculated using
formula (1) with the background activity being equal to the
mean activity within the background VOI and the “striatal
activity”being theactivity in thevoxel. ForeachVOI, a mean
SURmean and standard deviation SURSD was determined.
T h e s ev a l u e sw e r ed e t e r m i n e df o re a c hV O I( v), for each
phantom measurement (p) ,f o re a c ht y p eo fr e c o n s t r u c t i o n
(r), and for each smoothing kernel (s).
Since we would like to compare the diﬀerent recon-
structions with a variable smoothing kernel, the average
recovery (AR) and root mean squared coeﬃcient of variance
(RMSCOV) was then determined across all phantoms and
VOIs using the following formulae:
AR(r,s) =
100
npnv

v,p
SURmean

v, p,r,s

REF

v, p
 ,( 2 )
RMSCOV(r,s) = 100 ·
     1
npnv

v,p

SURSD

v, p,r,s

SURmean

v, p,r,s

	2
,
(3)
where REF(v, p) is the reference SUR value for a VOI v and
phantom measurement p as determined by the well counter
measurements.
np andnv arethenumberofphantommeasurementsand
the number of VOI’s, respectively.
These two values (both expressed in %) represent a
measure for “bias” (less bias corresponds to higher AR) and
“noise” (RMSCOV), respectively. The RMSCOV was plotted
against the average recovery (AR), with diﬀerent amounts of
smoothing producing a “bias-noise” curve for each type of
reconstruction.
In addition, using a similar methodology to Koch et
al. [14], the measured SUR determined from the SPECT
measurement and the true SUR determined from the
samples taken from the phantom chambers, were analysed
using scatter plots and compared by simple linear regression
analysis.
2.5. Patient Measurements. Fourteen patient studies were
performed on adult subjects with a primary diagnosis of4 International Journal of Molecular Imaging
(a) (b)
Figure 1: Striatal (red, green) and occipital (purple) volumes of interest used for the phantom study deﬁned using the CT image of the
phantom acquired with water in the background chamber and air in the striatal chambers (a). For the patient study using the Hermes Brass
software striatal (light green, orange, red, yellow) and occipital (dark blue) volumes were used (b). Frontal (light blue) and cerebellar (green)
volumes were not used for this study.
generalised social anxiety disorder (SAD) recruited from the
Anxiety Disorders Clinic of our tertiary hospital. All patients
were interviewed with the Structured Clinical Interview
for the Diagnosis of Axis-I Disorders to ascertain the
diagnosis according to diagnostic and statistical manual of
mental disorders (DSM IV) criteria [27]. Patients with other
primary psychiatric disorders, signiﬁcant medical illness,
or a neurological condition were excluded. No patients
were receiving psychotropic medication at the time of the
study.SPECT-CTscanningwasperformedafterapprovalwas
received from the Ethical Review Board of our institution.
2.6. SPECT-CT Imaging and Reconstruction. SPECT-CT
imaging was performed 3 hours after the administration of
a mean (standard deviation (SD)) dose of 134 (26) MBq of
[I-123]-(FP-CIT). SPECT-CT imaging was identical in every
respect to that performed for the phantom study, with the
exceptions of the rotational radius and the acquisition time.
The rotational radius was chosen so that the collimators
were as close as possible to the patient’s head, resulting in
a variation of 14.2–16.9cm. The time for each projection
was 20 seconds in 5 patients, 25 seconds in 8 patients, and
30 seconds in 1 patient. Reconstruction was identical to
that performed for the phantom data. Acquisition was done
according to 2010 EANM guidelines [21]e x c e p ti n3p a t i e n t s
(acquired counts at least 2.5M instead of 3M).
2.7. Analysis. All SPECT images were transformed to the
same space by ﬁtting to a FP-CIT template using BRASS
software (Hermes Medical Solutions, Sweden) [28, 29]. This
was done by applying a ﬁlter (Butterworth, order 5, cut oﬀ
0.9cm−1) to the unﬁltered SPECT image of each patient
obtained using nonuniform attenuation correction and
correction for collimator blurring using a variable point
spreadfunction.ThisﬁlteredimagewasthenﬁttedtotheFP-
CITtemplateusingBRASS.Thetransformobtainedwasthen
applied to each of the unﬁltered images for the 6 diﬀerent
attenuation corrections and collimator blurring options for
that patient.
Quantiﬁcation was performed with VOIs used by the
Brass software for the left and right caudate, left and right
putamen, and a posterior background VOI (Figure 1(b)).
The VOIs and the transformed SPECT images were con-
verted from interﬁle to ANALYZE format using MRIcro
software. For each of the 4 striatal VOIs and each of the
14 patients, a mean speciﬁc uptake ratio (SURmean) and its
standarddeviation(SURSD)weredeterminedsimilarlytothe
phantom study. The RMSCOV was again calculated using
(3) above for each reconstruction and smoothing kernel.
For the patient studies a true measure of striatal uptake
was not available. Therefore, for each reconstruction r and
smoothing s, the average SUR (aSUR) was determined using
the following formula:
aSUR(r,s) =
1
npnv

v,p
SURmean

v, p,r,s

,( 4 )
where np and nv are the number of patients and the number
of VOIs respectively.
It has been shown previously that the measured speciﬁc
uptake ratio SUR is proportional to the true SUR [14]. It
can therefore be expected that aSUR is proportional to AR,
making it a useful surrogate measure when true values are
not available. Therefore, we used aSUR as an alternative to
the average recovery AR.
Similar to the phantom studies, RMSCOV was plotted
against the aSUR, with diﬀerent amounts of smoothing pro-
ducing a surrogate “bias-noise” curve for each combination
of attenuation and collimator blurring correction.
2.8. Statistical Analysis. Evaluation of the curves requires
that comparison be performed for similar levels of noise,
or similar levels of bias, or a combination of the two. For
our analysis, we chose to minimize bias (maximal AR or
aSUR), while still having similar noise levels. This was done
by ﬁrst identifying the point of minimal bias (AR/ASUR)
across all reconstructions. The AR/ASUR at that point was
then compared to the AR/ASUR for other reconstructions
at similar noise levels. This was done by ﬁrst identifying
the point of minimum bias (AR/ASUR) across all recon-
structions. The AR/ASUR at that point was then compared
to the AR/ASUR for other reconstructions at similar noise
levels. This approach was used as a simple comparison of
points of minimal AR/ASUR for each reconstruction would
be diﬃcult to interpret given the large diﬀerences in noise
(RMSCOV) for the diﬀerent techniques. Comparison was
performed using a 2-way analysis of variance (ANOVA) with
repeated measures (factor 1: uniform or nonuniform attenu-
ation correction, factor 2: no, constant, or depth dependentInternational Journal of Molecular Imaging 5
collimatorblurringcorrection).Thisresultedinunsmoothed
collimator blurring reconstructions being compared to
reconstructions without collimator blurring with a similar
RMSCOV (Figures 2(a) and 2(b)). For the phantom study,
the measurements in each of the two striatal compartments
were taken separately in the 2-way ANOVA using repeated
measures, leading to 14 measurements per method. For the
patient study, the measurements of each of the 4 striatal
VOIs were taken separately leading to 56 measurements per
method.FindingswereconsideredsigniﬁcantforP<. 05and
reported as a trend for P<. 1.
3. Results
3.1. Phantom Measurements. Data was acquired using 7
phantomSPECT-CT studieswith14diﬀerentspeciﬁcuptake
ratios of I-123. True speciﬁc uptake ratio values were varied
from 2.08 to 14.70. Using unsmoothed nonuniform attenu-
ation and depth dependent collimator blurring corrections,
measured SUR values varied from 0.58 to 5.05. Total counts
for the studies varied from 3.2 to 3.8 million. There was a
close linear correlation (all with R2 > 0.96) between the mea-
sured and true SUR values for all reconstruction techniques
with higher values for the true SUR values, consistent with
ﬁndings described previously [14].
The “bias-noise” (AR-RMSCOV) curves are shown in
Figures 2(a) and 2(b). The curves obtained show a higher
average recovery (AR) and lower RMSCOV using nonuni-
form attenuation correction compared to uniform attenua-
tion correction. This was observed for images obtained both
with and without corrections for collimator blurring.
Comparing the diﬀerent methods (Figure 2(a)) using
the default value for the constant collimator blurring and
the measured depth dependent linear relation between psf
and distance (method 1, see Methods), we found a sig-
niﬁcant main eﬀect of the attenuation correction method
(F(1,13) = 5.67, P = .033) with higher AR values when
applying a CT based attenuation correction. No main eﬀect
of the method of correcting for collimator blurring was
found. A signiﬁcant interaction eﬀectbetweenthecorrection
for attenuation and the correction for collimator blurring
was observed (F(2,26) = 3.45, P = .047). Comparing
the diﬀerent methods (Figure 2(b)) using the optimized
values for constant and depth dependent collimator blurring
correction(method2,seemethods),wefoundasimilarmain
eﬀect of the attenuation correction method (F(1,13) = 4.92,
P = .045) but in this case we also found a signiﬁcant main
eﬀect of the method for correcting for collimator blurring
(F(2,26) = 12.47, P<. 001) with increased values of AR
for both the constant and the depth-dependent correction
compared to no correction. The interaction eﬀect showed a
trend (F(2,26) = 3.24, P = .056).
Unsmoothed reconstructions performed with collimator
blurring corrections (method 2) had a higher average
recovery (AR), and a lower noise (RMSCOV) compared
to reconstructions without collimator blurring corrections
(Table 1). However it is interesting to note that smoothing
of the images did not have the same eﬀect on images
obtained with and without corrections for collimator blur-
ring. Smoothing of reconstructions obtained using colli-
mator blurring corrections appears to be of little value as
the average recovery AR rapidly decreases for a relatively
modest decrease in RMSCOV. With smoothing using a
Gaussian kernel of larger than about 5mm FWHM, the
AR-RMSCOV curves of these reconstructions cross over the
curves for reconstructions without collimator blurring cor-
rections (Figure 2(b)), indicating that they then perform less
well. Conversely, smoothing of reconstructions performed
without collimator blurring initially results in a marked
improvement in the RMSCOV with a relatively modest loss
in average recovery AR.
3.2. Patient Measurements. Fourteen patient studies were
performed. Using unsmoothed nonuniform attenuation
correction and depth dependant collimator blurring correc-
tions, measured speciﬁc uptake ratio (SUR) values varied
from 1.49 to 5.43. Total counts for the studies varied from
2.5 to 6.4 million. The aSUR-RMSCOV curves are shown in
Figures 2(c) and 2(d). Results obtained from patient studies
are similar to those obtained from phantom data however
some key diﬀerences were noted.
The curves obtained again show a higher aSUR and
lower RMSCOV using nonuniform attenuation correction
compared to uniform attenuation correction, for images
obtained without corrections for collimator blurring. How-
ever a key diﬀerence was noted with the patient curves
when compared to those obtained with phantom data.
Collimator blurring corrected reconstructions obtained with
nonuniform attenuation correction resulted in lower aSUR
values than those with uniform attenuation correction. The
opposite was true for the phantom data.
Comparing (at a RMSCOV level similar to unsmoothed
reconstructions with collimator blurring correction) the
diﬀerent methods (Figure 2(c)) using the default value for
the constant collimator blurring and the measured depth
dependent linear relation between psf and distance (method
1, see Methods), we found a signiﬁcant main eﬀect for the
type of correction for collimator blurring (F(2,110) = 3.44,
P = .036) as well as a signiﬁcant interaction eﬀect between
the method for attenuation correction and the method for
correction of collimator blurring (F(2,110) = 23.84, P<
.001).Nosigniﬁcantmaineﬀectoftheattenuationcorrection
method was found.
The same results were found when comparing (at a
RMSCOV level similar to unsmoothed reconstructions
with collimator blurring correction) the diﬀerent methods
(Figure 2(d)) using the optimized values for constant and
depth dependent collimator blurring correction (method 2,
see methods): a signiﬁcant main eﬀect of the method for
collimator blurring (F(2,110) = 23.42, P<. 001) as well as a
signiﬁcant interaction eﬀect (F(2,110) = 26.23, P<. 001).
For reconstructions with uniform attenuation correc-
tion, correcting for collimator blurring (either constant or
depth dependent) achieved signiﬁcantly higher aSUR values
than not correcting for collimator blurring. This however
was not the case for reconstructions with nonuniform
attenuation correction, with the aSUR values not being6 International Journal of Molecular Imaging
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Figure 2: “Bias-noise” curves: plot of root mean squared coeﬃcient of variation (RMSCOV) versus average recovery (AR) for phantom data
(a and b) or versus the average speciﬁc uptake ratio (aSUR) for patient data (c and d). (a) give the results when using no correction for
collimator blurring, the default value (9.4mmFWHM) for the constant collimator blurring correction, and the measured depth dependent
collimator blurring correction (method 1, see text). (d) give the results when using the optimized values for the constant collimator blurring
correction or the depth dependent collimator blurring correction (method 2, see text). In the latter ﬁgures, we added the case when no
correction for collimator blurring is performed to help in the comparison with the top ﬁgures. (abbreviations: ct: nonuniform attenuation
correction using a CT-based attenuation map; ell: uniform attenuation correction using an ellipse approximating the scalp; p0, pc, pd: no,
constant, and depth dependent correction for collimator blurring, respectively; FWHM: full width at half maximum).
Table 1: Average recovery (AR) and root mean squared coeﬃcient of variation (RMSCOV) values for unsmoothed reconstructions, (abbre-
viations: p0, pc, pd: no, constant, and depth dependent correction for collimator blurring resp.).
Collimator blurring AR RMSCOV
CT p0 31.0 71.3
Based pc (method 1) 30.8 63.4
Attenuation pc (method 2) 32.5 63.7
Correction pd (method 1) 30.3 64.3
pd (method 2) 32.5 63.4
Uniform p0 29.9 74.1
Based pc (method 1) 29.3 67.1
Attenuation pc (method 2) 31.1 66.6
Correction pd (method 1) 28.8 68.1
pd (method 2) 31.1 66.4International Journal of Molecular Imaging 7
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Figure 3: Plot of average recovery (AR) for a single phantom study
(using unsmoothed data) as a function of translational SPECT-CT
mis-registration(perpendiculartothetomographicaxisofrotation,
1 pixel = 2.95mm) or rotational SPECT mis-registration (around
the axis of the tomographic axis of rotation), (abbreviations: ct:
nonuniform attenuation correction using a CT-based attenuation
map; p0, pd: no, and depth dependent correction for collimator
blurring,resp.,basedontheoptimizedmethod).Thesolidlinegives
the AR value calculated using uniform attenuation correction and
depth dependent correction for collimator blurring.
signiﬁcantly higher. From another perspective, unlike the
phantom data, for this patient population given similar
RMSCOV values (i.e., at similar noise levels), reconstruc-
tions with uniform attenuation correction combined with
correctionforcollimatorblurringachievethehighestaverage
speciﬁc uptake ratio (aSUR).
4. Discussion
In this study, the eﬀects of (1) nonuniform attenuation
correction and (2) correction for collimator blurring were
determined for striatal SPECT imaging. It was found that
nonuniform attenuation correction resulted in improved
quantiﬁcation of striatal SPECT images. When using an
additional correction for collimator blurring, the bias was
lowest (i.e., the highest average recovery AR). This however
was not seen with the patient studies, with the combination
of a uniform attenuation correction and a correction for
collimatorblurringleadingtothelowestbias(i.e.,thehighest
average SUR).
The diﬀerent techniques used in this study resulted in
images of diﬀering smoothness, even after applying the
same postsmoothing, complicating the comparison of the
reconstruction methods. Without taking this into account it
is possible that one technique may appear superior when this
is in fact not the case. The creation of “bias-noise” curves (in
ourstudyrepresentedbyAR-RMSCOVandaSUR-RMSCOV
curves) assisted with a comparison of these techniques
independent of this potentially important confound. A noise
(RMSCOV) level similar to that of unsmoothed collimator
blurring corrected images was chosen to compare the
methods as this was regarded as a level that is appropriate
for reading of the scans visually. The “bias-noise” curves
enabled the selection of appropriate points on curves for
reconstructions without collimator blurring for comparison.
In addition the curves made it possible to observe the
diﬀering eﬀects of smoothing on images reconstructed
in diﬀerent ways. In the case of images generated using
collimator blurring corrections, further smoothing appears
to be of little value resulting in a rapid decline in average
recovery AR or average speciﬁc uptake ratio aSUR, with a
modest decrease in noise. Conversely, a degree of smoothing
or ﬁltering is essential for images reconstructed without
collimator blurring, resulting in a marked decrease in noise
with little loss in the average recovery AR or speciﬁc uptake
ratio aSUR.
Nonuniform attenuation correction alone as opposed
to uniform attenuation correction alone resulted in SPECT
images with speciﬁc uptake ratio values that were closer to
the true values known from phantom data. These results
concur with previous work suggesting some beneﬁt in the
use of nonuniform attenuation correction for brain SPECT
[10–12].
The use of corrections for collimator blurring during
reconstruction resulted in a marked increase in average
recovery (AR) and average speciﬁc uptake ratio (aSUR)
values. In this study, striatal SPECT data obtained using
both an anthropomorphic phantom, and patient studies
provide support for the results of previous studies using
simulated data [6, 7]. This was true for corrections using
both a constant and a depth-dependant PSF. Although a
depth-dependant PSF resulted in a higher average speciﬁc
uptake ratio aSUR value, compared to a constant PSF, the
diﬀerences were very small.
Perhaps the most interesting ﬁndings of this study
were the results obtained when nonuniform attenuation
correction and collimator blurring corrections were used
together. Intuitively, one would expect that this combination
would result in a further increase in the average recovery
and speciﬁc uptake ratio. This was indeed the case for8 International Journal of Molecular Imaging
the values obtained using the phantom data. The use of
both correction methods resulted in an average recovery
that was increased compared to the case when nonuniform
attenuation correction alone was applied. This was also the
case when a uniform attenuation correction was applied in
combinationwithacollimatorblurringcorrection.However,
the ﬁndings for the patient data revealed a diﬀerent result.
For the patient studies, the highest average speciﬁc uptake
ratio aSUR was achieved using collimator blurring correc-
tions in combination with a uniform attenuation correction.
The reason for this ﬁnding is not immediately clear; however
the combination of patient data, nonuniform attenuation
and collimator blurring corrections unexpectedly leads to
a suboptimal result. It can be speculated that patient
studies are likely to have small misregistrations between the
SPECT and CT studies due to patient movement between
the acquisitions, something that should not occur with
a phantom study. These small mis-registrations may not
have a major impact on reconstructions with nonuniform
attenuation correction for the striatal regions but recon-
structions with collimator blurring corrections may be more
sensitive to them. Based on a visual assessment, there were
no marked mis-registrations of the patient data used in
this study, but it is possible, however, that there may be
subtle diﬀerences, not seen with visual inspection. To further
test this explanation, a single phantom study was taken
and deliberate SPECT-CT translational and rotational mis-
registrations were introduced. The mis-registered data were
then reconstructed using uniform attenuation correction
combined with a depth dependent collimator blurring
correction, nonuniform attenuation correction alone, and
nonuniform attenuation correction combined with a correc-
tion for collimator blurring. Rotational mis-registration up
to 4 degrees was found to have little eﬀect on striatal AR, but
a translational mis-registration of 3–6mm (1-2 pixels) gave
a result similar to that obtained for the patient data above,
that is, the highest recovery was obtained for reconstruction
with a uniform attenuation correction and combined with a
collimator blurring correction (Figure 3).
This study shows that care must be taken with extrap-
olating the optimal reconstruction technique derived from
phantom data to real patient data. In practice, we do have
to deal with small deviations from the perfect situation and
a method sensitive to small errors may not be optimal. This
mightbe thecasewhenusinga CT-basedattenuationcorrec-
tion combined with a correction for collimator blurring.
The AR for the phantom study varied from about 28 to
33%, which is relatively low compared to data from simu-
lation studies. However, this is comparable with published
workwithanthropomorphicphantomstudiesusingasimilar
dual headed gamma camera-collimator combination [14].
Based on the results of our study, we can select the
optimal reconstruction technique depending on the choice
of the noise level, the level of bias, or a combination. In
Tygerberg Hospital, we aim for images with low bias and
an acceptable level of noise. Therefore, we are currently
using a uniform attenuation correction combined with a
depthdependentcorrectionforcollimatorblurringusingthe
optimized method.
5. Conclusion
This study suggests that particularly when quantiﬁcation is
required, an optimal brain SPECT reconstruction (in terms
of the lowest bias) in patients would include a correction for
collimator blurring and uniform attenuation correction.
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